StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.75−0.00 (-0.32%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Scinai Immunotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Scinai Immunotherapeutics's pe ratio was 6.4× on Feb 27, 2026, against 2.2× a year earlier. Over the last 3 years it ranged from 1.2× to 6.4×, with a median of 2.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20266.4×+4.2
2025Dec 31, 20252.2×+0.2
2024Dec 31, 20242.1×+0.6
2023Dec 29, 20231.5×–

More Scinai Immunotherapeutics figures

See a number that looks wrong?